Status:
UNKNOWN
Volatiles in Breath and Headspace Analysis - Diagnostic Markers
Lead Sponsor:
University of Latvia
Collaborating Sponsors:
Technion, Israel Institute of Technology
Riga East University Hospital
Conditions:
Tuberculosis
Gastric Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Detection of Volatile Organic Compounds (VOC) directly from tissue by headspace analysis (skin, surgery material, other tissue) and exhaled breath is feasible using affordable user-friendly novel nano...
Detailed Description
Study propose to explore a novel approach for the diagnosis and monitoring of diseases. The approach is based on the detection of volatile organic compounds (VOCs) that are emitted from the cells and ...
Eligibility Criteria
Inclusion
- Informed Consent signed
- Individual with targeted disease/lesion (tuberculosis, gastric cancer, gastric dysplasia, high/ normal/ low risk gastric lesions, colorectal cancer, high-risk colorectal lesions, low-risk colorectal adenoma, pancreatic cancer, chronic pancreatitis, liver cancer, chronic liver disease, other infectious diseases, oncological diseases of other location)
Exclusion
- Informed Consent not signed
- Other active cancer at the time of inclusion for particular study group
Key Trial Info
Start Date :
July 24 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT03228095
Start Date
July 24 2017
End Date
December 31 2025
Last Update
August 21 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Latvia
Riga, Latvia, LV 1586